BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37661460)

  • 1. The Need for Serum Testosterone Measurement with Liquid Chromatography and Tandem Mass Spectrometry in Prostate Cancer Patients Undergoing Castration.
    Morote J; Aguilar A; Trilla E
    Eur Urol Oncol; 2024 Apr; 7(2):311. PubMed ID: 37661460
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients.
    Morote J; Comas I; Ferrer R; Planas J; Celma A; Regis L
    J Biomed Sci; 2017 Oct; 24(1):81. PubMed ID: 29058606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.
    van der Sluis TM; Bui HN; Meuleman EJ; Heijboer AC; Hartman JF; van Adrichem N; Boevé E; de Ronde W; van Moorselaar RJ; Vis AN
    J Urol; 2012 May; 187(5):1601-6. PubMed ID: 22425112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum testosterone measured by liquid chromatography-tandem mass spectrometry is an independent predictor of response to castration in metastatic hormone-sensitive prostate cancer.
    van Winden LJ; Lanfermeijer M; Dezentje V; Bergman AM; van der Poel HG; van Rossum HH
    Clin Chim Acta; 2023 Jan; 539():34-40. PubMed ID: 36460134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of methods for quantifying serum testosterone in patients with prostate cancer who underwent castration.
    Comas I; Ferrer R; Planas J; Celma A; Regis L; Morote J
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):86-93. PubMed ID: 28259362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Testosterone Levels in Prostate Cancer Patients Undergoing Luteinizing Hormone-Releasing Hormone Agonist Therapy.
    Morote J; Comas I; Planas J; Maldonado X; Celma A; Placer J; Ferrer R; Carles J; Regis L
    Clin Genitourin Cancer; 2018 Apr; 16(2):e491-e496. PubMed ID: 29198640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone analysis in castrated prostate cancer patients: suitability of the castration cut-off and analytical accuracy of the present-day clinical immunoassays.
    van Winden LJ; Lentjes EGWM; Demir AY; Huijgen HJ; Bergman AM; van der Poel HG; van Rossum HH
    Clin Chem Lab Med; 2022 Sep; 60(10):1661-1668. PubMed ID: 35918785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.
    Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Taguri M; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
    Prostate; 2016 Mar; 76(4):376-82. PubMed ID: 26616365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry.
    Upreti R; Naredo G; Faqehi AM; Hughes KA; Stewart LH; Walker BR; Homer NZ; Andrew R
    Talanta; 2015 Jan; 131():728-35. PubMed ID: 25281165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Cortisol and Testosterone in Athletes: Accuracy of Liquid Chromatography-Tandem Mass Spectrometry Assays for Cortisol and Testosterone Measurement in Whole-Blood Microspecimens.
    Fragala MS; Goldman SM; Goldman MM; Bi C; Colletti JD; Arent SM; Walker AJ; Clarke NJ
    J Strength Cond Res; 2018 Sep; 32(9):2425-2434. PubMed ID: 29985225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple and accurate candidate reference measurement procedure for total testosterone in human serum by one-step liquid-liquid extraction coupled with isotope dilution mass spectrometry.
    Chen Y; Teo HL; Liu H; Loh TP; Liu Q; Teo TL; Lee TK; Sethi SK
    Anal Bioanal Chem; 2019 Nov; 411(28):7519-7528. PubMed ID: 31630222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT).
    Tiwari R; Lajkosz K; Berjaoui M; Qaoud Y; Kenk M; Woffendin C; Caron P; Guillemette C; Fleshner N
    Urol Oncol; 2022 May; 40(5):193.e15-193.e20. PubMed ID: 35437219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurement of testosterone, androstenedione and dehydroepiandrosterone (DHEA) in serum and plasma using Isotope-Dilution 2-Dimension Ultra High Performance Liquid-Chromatography Tandem Mass Spectrometry (ID-LC-MS/MS).
    Büttler RM; Martens F; Kushnir MM; Ackermans MT; Blankenstein MA; Heijboer AC
    Clin Chim Acta; 2015 Jan; 438():157-9. PubMed ID: 25172041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of total estradiol and testosterone in human serum by isotope dilution liquid chromatography tandem mass spectrometry.
    Zhou H; Wang Y; Gatcombe M; Farris J; Botelho JC; Caudill SP; Vesper HW
    Anal Bioanal Chem; 2017 Oct; 409(25):5943-5954. PubMed ID: 28801832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography tandem mass spectrometry.
    Chen Y; Yazdanpanah M; Wang XY; Hoffman BR; Diamandis EP; Wong PY
    Clin Biochem; 2010 Mar; 43(4-5):490-6. PubMed ID: 20026023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a high throughput method for serum/plasma testosterone using liquid chromatography tandem mass spectrometry (LC-MS/MS).
    Singh RJ
    Steroids; 2008 Dec; 73(13):1339-44. PubMed ID: 18703076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS assay for the quantification of testosterone, dihydrotestosterone, androstenedione, cortisol and prednisone in plasma from castrated prostate cancer patients treated with abiraterone acetate or enzalutamide.
    van Nuland M; Venekamp N; Wouters WME; van Rossum HH; Rosing H; Beijnen JH
    J Pharm Biomed Anal; 2019 Jun; 170():161-168. PubMed ID: 30925273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of serum testosterone levels by LC-MS/MS in chemically castrated prostate cancer patients: Biological variation and analytical performance specifications.
    van Winden LJ; Lanfermeijer M; Heijboer AC; van Tellingen O; Bergman AM; van der Poel HG; Jonker N; van Rossum HH
    Clin Chim Acta; 2021 Oct; 521():70-75. PubMed ID: 34217697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Measurement of Serum Chemical Castration Agents and Testosterone Levels Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Ko DH; Lee K; Jeon SH; Song SH; Yun YM; Chun S; Kim HS; Kim JY; In MK; Song J
    J Anal Toxicol; 2016 May; 40(4):294-303. PubMed ID: 26989223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum.
    Botelho JC; Shacklady C; Cooper HC; Tai SS; Van Uytfanghe K; Thienpont LM; Vesper HW
    Clin Chem; 2013 Feb; 59(2):372-80. PubMed ID: 23213081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.